These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27498456)

  • 21. Attitudes and behavior of privately-funded biomedical scientists.
    Krimsky S
    Account Res; 2009; 16(2):75-7. PubMed ID: 19353386
    [No Abstract]   [Full Text] [Related]  

  • 22. [Conflict of interests in clinical research].
    Alves EM; Tubino P
    Acta Cir Bras; 2007; 22(5):412-5. PubMed ID: 17923964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research Ethics in IR: The Intersection Between Care and Progress.
    Bozorghadad S; Newton IG; Perez AW; Makary MS; Keller EJ
    J Vasc Interv Radiol; 2020 May; 31(5):846-848. PubMed ID: 32359529
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-financial conflicts of interests in psychiatric research and practice.
    Maj M
    Br J Psychiatry; 2008 Aug; 193(2):91-2. PubMed ID: 18669986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [For and against: does sponsoring impede the growth of knowledge in medicine?].
    Finzen A; Fritze J
    Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

  • 27. The Society for Academic Emergency Medicine position on ethical relationships with the biomedical industry.
    Schears RM; Watters A; Schmidt TA; Marco CA; Larkin GL; Marshall JP; Mason JD; McBeth BD; Mello MJ;
    Acad Emerg Med; 2007 Feb; 14(2):179-81. PubMed ID: 17185294
    [No Abstract]   [Full Text] [Related]  

  • 28. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 29. Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges.
    Kirch DG
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S23-5; discussion S32-7. PubMed ID: 17471619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conflict of interest.
    Krimsky S
    New Sci; 2003 Aug; 179(2410):21. PubMed ID: 14982075
    [No Abstract]   [Full Text] [Related]  

  • 31. Which research is to be believed? The ethics of industrial funding of orthopaedic research.
    Carr AJ
    J Bone Joint Surg Br; 2005 Nov; 87(11):1452-3. PubMed ID: 16260655
    [No Abstract]   [Full Text] [Related]  

  • 32. A statement on ethics from the HEART group.
    HEART Group
    Catheter Cardiovasc Interv; 2008 May; 71(6):859-61. PubMed ID: 18412086
    [No Abstract]   [Full Text] [Related]  

  • 33. [The medical-industrial complex: an ethical challenge].
    Engelhardt K
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
    [No Abstract]   [Full Text] [Related]  

  • 34. A perspective on commercial relationships between ophthalmology and industry.
    Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
    Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings of a national dialogue on biomedical conflicts of interest and innovation management. September 20, 2006. Cleveland, Ohio, USA.
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S3-80. PubMed ID: 17566157
    [No Abstract]   [Full Text] [Related]  

  • 36. Research from tobacco industry affiliated authors: need for particular vigilance.
    Chapman S
    Tob Control; 2005 Aug; 14(4):217-9. PubMed ID: 16046673
    [No Abstract]   [Full Text] [Related]  

  • 37. Sponsorship by Big Oil, Like the Tobacco Industry, Should be Banned by the Research Community.
    Kogevinas M; Takaro T
    Epidemiology; 2019 Sep; 30(5):615-616. PubMed ID: 31180931
    [No Abstract]   [Full Text] [Related]  

  • 38. Flaws in the medical literature: who's to blame?
    Kassirer JP
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):395-7. PubMed ID: 20872281
    [No Abstract]   [Full Text] [Related]  

  • 39. American Society of Clinical Oncology policy for relationships with companies: background and rationale.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2037-42. PubMed ID: 23610121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Industry relations.
    Shortell CK
    J Vasc Surg; 2011 Sep; 54(3 Suppl):1S-2S. PubMed ID: 21872106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.